Narcolepsy Market Developments and Opportunities Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Narcolepsy Market Over The 2026–2030 Period?

The narcolepsy market size has seen rapid growth in recent years. It is forecast to grow from $3.95 billion in 2025 to $4.38 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. The historic period’s growth can be ascribed to a combination of limited awareness of narcolepsy, protracted diagnosis rates, dependence on stimulant medications, the emergence of sodium oxybate, and an increase in sleep disorder research.

The narcolepsy market is projected for significant expansion shortly, reaching $6.62 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.9%. This anticipated growth is attributable to factors such as the increasing incidence of sleep disorders, greater investment in research and development, an expanding pipeline of non-stimulant therapies, more patient education programs, and progress in precision medicine. Key trends shaping the forecast period encompass heightened awareness and diagnosis of narcolepsy, a greater uptake of combination therapies, increasing demand for long-acting treatments, a broader range of non-stimulant options, and a stronger emphasis on cataplexy-specific treatments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16491&type=smp

Which Factors Are Influencing The Growth Of The Narcolepsy Market?

The increasing prevalence of obesity is projected to drive the growth of the narcolepsy market moving forward. Obesity is a medical condition marked by an excessive build-up of body fat, presenting a health risk. The rise in obese individuals is attributed to increasingly sedentary lifestyles, inadequate dietary habits, and environmental factors promoting consumption of calorie-dense foods and reduced physical activity. Obesity can lead to narcolepsy through the disruption of metabolic and hormonal balances, potentially affecting sleep patterns and wakefulness regulation. For instance, in May 2025, the Office for Health Improvement & Disparities, a UK-based government department, reported that an estimated 64.5 percent of adults aged 18 and over in England were overweight or living with obesity in 2023–2024, an increase from 64.0 percent in 2022–2023, illustrating a continuous upward trend. Therefore, the growing number of obese people is propelling the growth of the narcolepsy market.

How Are Segments Identified Within The Narcolepsy Market Segment Framework?

The narcolepsy market covered in this report is segmented –

1) By Type: Type 1, Type 2

2) By Treatment: Antidepressants, Stimulants, Sodium Oxybate, Other Treatments

3) By Diagnosis: Polysomnogram, Multiple Sleep Latency Test

Subsegments:

1) By Type 1: Stimulant Medications, Antidepressants, Sodium Oxybate, Immunosuppressive Treatments

2) By Type 2: Stimulant Medications, Sodium Oxybate, Antidepressants

Which Trends Are Influencing Demand In The Narcolepsy Market?

Leading companies within the narcolepsy market are intensifying their efforts to develop innovative medications, such as extended-release sodium oxybate, aiming to meet the rising demand for effective therapies. Extended-release sodium oxybate is a pharmaceutical agent utilized in the treatment of narcolepsy. Its extended-release characteristic facilitates a regulated discharge of the drug over an extended duration, thus providing continuous symptom relief throughout the night and improving the quality of sleep for individuals living with narcolepsy. For example, in June 2023, Avadel Pharmaceuticals plc, an Ireland-based pharmaceutical company, introduced LUMRYZ in the United States. LUMRYZ is an extended-release variant of sodium oxybate, which received approval from the FDA for managing cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. It holds the distinction of being the first and only once-at-bedtime oxybate treatment for narcolepsy, presenting a notable enhancement compared to twice-nightly oxybate products by removing the necessity for a second dose during the night.

Who Are The Companies Competing Within The Narcolepsy Market?

Major companies operating in the narcolepsy market are Pfizer Inc., Merck & Co. Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries, Otsuka Pharmaceutical, Sumitomo Pharma Company Limited, Jazz Pharmaceuticals, Alkermes, Harmony Biosciences, Cerevel Therapeutics, Axsome Therapeutics Inc., Avadel Pharmaceuticals, NLS Pharmaceutics AG, KemPharm, Bioprojet Pharma, Centessa Pharmaceuticals, Hikma Pharmaceuticals, Theranexus SA, Eisai Co Ltd, Ligand Pharmaceuticals, Graymark Healthcare Inc, H Lundbeck A/S

Get The Full Narcolepsy Market Report:

https://www.thebusinessresearchcompany.com/report/narcolepsy-global-market-report

Which Region Is The Largest In The Narcolepsy Market?

North America was the largest region in the narcolepsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the narcolepsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Narcolepsy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/narcolepsy-global-market-report

Browse Through More Reports Similar to the Global Narcolepsy Market 2026, By The Business Research Company

Core Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/core-materials-global-market-report

Biomaterials Market Report

https://www.thebusinessresearchcompany.com/report/biomaterials-global-market-report

Biosurgery Market Report

https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795